Download PDF
1 / Pages

Other users also viewed these articles

RIPK3 and kidney disease Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;
Nefrologia (English Version). 2024;44:10-22
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;
Nefrologia (English Version). 2025;45:214-27
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project Juan F. Navarro González; Alberto Ortiz; Ana Cebrián Cuenca; Marta Moreno Barón; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:807-17